Related Experiment Video
Updated: Jun 18, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Raltegravir use in special populations.
1Royal Free Hospital NHS Trust, University College, London, UK. Margaret.Johnson@royalfree.nhs.uk
European Journal of Medical Research
|December 5, 2009
Summary
Raltegravir is a virologically effective integrase inhibitor with good tolerability. This review explores its use in special populations, including transplant patients, those on chemotherapy, and individuals with specific complications or comorbidities.
Area of Science:
- Infectious Diseases
- Pharmacology
- Virology
Background:
- Raltegravir is the first approved integrase inhibitor.
- It demonstrates virologic efficacy in clinical trials for treatment-naive and triple-class resistant patients.
- Raltegravir possesses an excellent tolerability profile with minimal drug-drug interactions.
Purpose of the Study:
- To review the use of raltegravir in special patient populations.
- To discuss its application in solid organ and bone marrow transplantation.
- To explore indications beyond standard HIV treatment, including specific comorbidities and adverse effects.
Main Methods:
- Review of clinical trial data and published literature.
- Analysis of raltegravir's efficacy and safety in diverse patient groups.
- Identification of potential roles in specialized treatment scenarios.
Main Results:
- Raltegravir is effective in treatment-naive and resistant HIV populations.
- Its favorable tolerability and interaction profile support use in complex cases.
- Potential applications include transplant recipients, cancer patients, and those with metabolic issues or side effects.
Conclusions:
- Raltegravir is a valuable therapeutic option for various special patient populations.
- Its use may extend to pregnant women with resistance or tolerability concerns.
- Further consideration is warranted for raltegravir in managing HIV in complex clinical settings.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:15Drug Dosage Regimen: Overview
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...